Therefore, we propose the potential therapeutic mechanism of BAC treatment as the following: BAC restored secondary bile acid metabolism to increase levels of UDCA and LCA, which induced the activation of TGR5 to improve gut-barrier integrity and reduce inflammation in murine colitis. This evidence concerns the gene GPBAR1 and colitis.